Coronavirus information

Visitor restrictions, information for patients and more.

View coronavirus information

FOI 0610 Dermatology Patient Treatments 2019/20

Freedom of Information Request: FOI 0610 2019/20

Could you please provide me with the following numbers of patients treated in the last 12 months with the following drugs.

Adalimumab [Amgevita] 15
Adalimumab [Hulio] 15
Adalimumab [Humira] 146
Adalimumab [Hyrimoz] 15
Adalimumab [Imraldi] 15
Apremilast [Otezla] 23
Brodalumab [Kyntheum] 1
Certolizumab [Cimzia] 0
Dimethyl fumarate [Skilarence] 10
Dupilumab [Dupixient] 44
Etanercept [Benepali] 4
Etanercept [Enbrel] 9
Etanercept [Erelzi] 5
Golimumab [Simponi] 0
Guselkumab [Tremfya] 39
Infliximab [Flixabi] 0
Infliximab [Inflectra] 214
Infliximab [Remicade] 26
Infliximab [Remsima] 0
Ixekizumab [Taltz] 10
Risankizumab [Skyrizi] 0
Secukinumab [Cosentyx] 76
Tildrakizumab [Ilumetri] 1
Tocilizumab [Ro Actemra] 0
Upadacitinib [Rinvoq] 0
Ustekinumab [Stelara] 116

 

If you are unable to provide the information above with specific reference to dermatology then please provide me with the numbers of patients treated in the last 12 months with the above drugs, regardless of disease/indication.

 

Thinking of going to Accident and Emergency but not sure if you need to? Try our handy symptom checker.

Try ask A&E

We're improving the accessibility of our websites. If you can't access any content or if you would like to request information in another format, please view our accessibility statement.